- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT02740686
Changes in Inflammatory Markers During Pulmonary Rehabilitation Based on Exacerbation States in COPD (CIMPRES-COPD)
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
Typ studiów
Zapisy (Rzeczywisty)
Kontakty i lokalizacje
Lokalizacje studiów
-
-
-
Lincoln, Zjednoczone Królestwo, LN2 2EF
- Sudbrooke Drive Community Centre
-
Lincoln, Zjednoczone Królestwo, LN5 8QS
- Bracebridge Community Centre
-
-
Lincolnshire
-
Lincoln, Lincolnshire, Zjednoczone Królestwo, LN2 2JP
- Lindum Medical Practice
-
Lincoln, Lincolnshire, Zjednoczone Królestwo, LN2 2RS
- Nettleham Medical Practice
-
Lincoln, Lincolnshire, Zjednoczone Królestwo, LN6 0QQ
- Birchwood Medical Practice
-
Lincoln, Lincolnshire, Zjednoczone Królestwo, LN2 3JH
- Welton Surgery
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
116 COPD patients, confirmed by diagnosis, will be recruited (58 frequent and 58 infrequent exacerbators in accordance with criteria listed above) to the study who have been referred to, and are about to enrol, on pulmonary rehabilitation.
20 healthy smokers and 20 healthy never smokers will be recruited for baseline measurements to compare with COPD patients.
Opis
Inclusion Criteria:
- 58 frequent exacerbators and 58 infrequent exacerbators (116 in total) who have been diagnosed with any severity of COPD (according to BTS criteria, i.e. >10 pack year smoking history and post bronchodilator spirometry FEV1/FVC ratio <0.70 and FEV<80%).
Exclusion Criteria:
- Inability or unwillingness to sign informed consent
- Any unstable ongoing cardiovascular events which may be exacerbated by exercise
- Inability to complete walk tests due to physical or mental impairment
- Other active inflammatory conditions e.g. rheumatoid arthritis, cancer.
- Known asthma, allergic rhinitis or other respiratory disease (bronchiectasis, pulmonary fibrosis)
Healthy control group - Patients who have not been diagnosed with COPD or any other respiratory condition and are characteristically (age (between 45-85 years old) & smoking status) matched to recruited COPD patients.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
Kohorty i interwencje
Grupa / Kohorta |
Interwencja / Leczenie |
---|---|
Frequent exacerbators
Exacerbations will be defined as "a respiratory event which led to a hospitalisation or the prescription of antibiotics and/or oral corticosteroids".
Clinicians will ask patients to retrospectively recall how many exacerbations they have had in the past 12 months.
Patients will be allocated to the frequent exacerbators group based on whether they have had 2 or more hospitalisations for exacerbations or have taken 2 or more courses on steroids/antibiotics within the past 12 months.
Blood sample collection at the following pulmonary rehabilitation sessions: 1st (pre-exercise), 2nd (pre and post-exercise), 8th (pre-exercise), last session (pre and post exercise).
Sputum samples collected pre-exercise at the following pulmonary rehabilitation sessions: 1st, 8th, and last session.
|
Frequent exacerbators and infrequent exacerbators will have blood and sputum samples obtained around pulmonary rehabilitation.
No other intervention will be administered.
Healthy controls will have resting blood samples taken.
|
Infrequent exacerbators
Exacerbations will be defined as "a respiratory event which led to a hospitalisation or the prescription of antibiotics and/or oral corticosteroids".
Clinicians will ask patients to retrospectively recall how many exacerbations they have had in the past 12 months.
Patients will be allocated to the infrequent exacerbators group based on whether they have had no more than 1 hospitalisation for exacerbations or have not taken more than 1 course of steroids/antibiotics within the past 12 months.
Blood sample collection at the following pulmonary rehabilitation sessions: 1st (pre-exercise), 2nd (pre and post-exercise), 8th (pre-exercise), last session (pre and post exercise).
Sputum samples collected pre-exercise at the following pulmonary rehabilitation sessions: 1st, 8th, and last session.
|
Frequent exacerbators and infrequent exacerbators will have blood and sputum samples obtained around pulmonary rehabilitation.
No other intervention will be administered.
Healthy controls will have resting blood samples taken.
|
Healthy smokers
Recruited in accordance with inclusion/exclusion criteria with no medical history of COPD diagnosis and currently smoke.This group will be recruited by a nurse using medical records to assess smoking status and age-matching to the COPD groups.
A resting blood sample will be taken from these patients and used to compare baseline measurements with the COPD groups.
|
Frequent exacerbators and infrequent exacerbators will have blood and sputum samples obtained around pulmonary rehabilitation.
No other intervention will be administered.
Healthy controls will have resting blood samples taken.
|
Healthy never smokers
Recruited in accordance with inclusion/exclusion criteria with no medical history of COPD diagnosis and have never smoked.This group will be recruited by a nurse using medical records to assess smoking status and age-matching to the COPD groups.
Resting blood samples will be taken from these patients and used to compare baseline measurements with the COPD groups.
|
Frequent exacerbators and infrequent exacerbators will have blood and sputum samples obtained around pulmonary rehabilitation.
No other intervention will be administered.
Healthy controls will have resting blood samples taken.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Ramy czasowe |
---|---|
Concentration of inflammatory markers in plasma and sputum (C-reactive protein, Fibrinogen, Interleukin(IL)-6, IL-8
Ramy czasowe: July 2016 - August 2018
|
July 2016 - August 2018
|
Miary wyników drugorzędnych
Miara wyniku |
Ramy czasowe |
---|---|
Changes in the expression of anti-inflammatory genes
Ramy czasowe: July 2016 - August 2018
|
July 2016 - August 2018
|
Total and differential blood leukocyte count
Ramy czasowe: July 2016 - August 2018
|
July 2016 - August 2018
|
Pre-activation and activation of blood neutrophils using flow cytometry
Ramy czasowe: July 2016 - August 2018
|
July 2016 - August 2018
|
Pro-coagulant and pro-inflammatory microparticle signatures in plasma
Ramy czasowe: July 2016 - August 2018
|
July 2016 - August 2018
|
Severe, moderate and mild exacerbations (number of /days to defined events, severity, recovery)
Ramy czasowe: July 2016 - August 2018
|
July 2016 - August 2018
|
Respiratory Symptoms™ (RS-Total score; RS-Breathlessness; RS-Cough and Sputum, and RS-Chest Symptoms)
Ramy czasowe: July 2016 - August 2018
|
July 2016 - August 2018
|
Routine clinical outcome measures following pulmonary rehabilitation (completion rates and clinically important differences - ISWT, ESWT, 6MWD, CRQ)
Ramy czasowe: July 2016 - August 2018
|
July 2016 - August 2018
|
Differences in basal levels of inflammation between frequent and infrequent exacerbators in comparison to healthy controls
Ramy czasowe: July 2016 - August 2018
|
July 2016 - August 2018
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Śledczy
- Główny śledczy: Alex R Jenkins, MPhil, PhD student
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 16/LO/0865
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Przewlekła obturacyjna choroba płuc
-
Spero TherapeuticsZakończonyKompleks Mycobacterium Avium | Niegruźlicze Mycobacterium Pulmonary DiseaseStany Zjednoczone
Badania kliniczne na Sample collection
-
Cliniques universitaires Saint-Luc- Université...Université de LiègeRekrutacyjnyMukowiscydoza | BiomarkeryBelgia
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RekrutacyjnyRakotwórcza otrzewnej | Nowotwór układu pokarmowego | Rak wątroby i dróg żółciowych wewnątrzwątrobowych | Rak wyrostka robaczkowego według etapu AJCC V8 | Rak jelita grubego wg AJCC V8 Stage | Rak przełyku według etapu AJCC V8 | Rak żołądka wg AJCC V8 StageStany Zjednoczone
-
Memorial Sloan Kettering Cancer CenterZakończonyRak prostatyStany Zjednoczone
-
Immodulon Therapeutics LtdZakończonyCzerniakZjednoczone Królestwo